A Case of Mantle Cell Lymphoma Treated with Autologous Stem Cell Transplantation and Rituximab

So-Yeon OH; Moon-Ju JANG; Sei-Kyung CHANG; Doyeon OH; So-Young CHONG; So-Yeon OH; Moon-Ju JANG; Sei-Kyung CHANG; Doyeon OH; So-Young CHONG.
Korean Journal of Hematology ; : 215-219, 2006.
Artículo en Ko | WPRIM | ID: wpr-720717

Documentos relacionados

  1. Treatment patterns and clinical outcomes of mantle cell lymphoma: A retrospective cohort study by CHOICE.
  2. Immunochemotherapy plus lenalidomide for high-risk mantle cell lymphoma with measurable residual disease evaluation.
  3. Ofatumumab plus HyperCVAD/HD-MA induction leads to high rates of minimal residual disease negativity in patients with newly diagnosed mantle cell lymphoma: Results of a phase 2 study.
  4. Update on mantle cell lymphoma.
  5. [Intraocular invasion of bilateral primary ocular adnexal mantle cell lymphoma: a case report].
  6. Mantle-Cell Lymphoma.
  7. Genetic and prognostic analysis of blastoid and pleomorphic mantle cell lymphoma: a multicenter analysis in China.
  8. Clinical characteristics and outcomes of ocular adnexal mantle cell lymphoma.
  9. [Mantle Cell Lymphoma -  Cutting edge Dia-gnostics and Treatment Approaches].
  10. Death from mantle cell lymphoma limits sequential therapy, particularly after first relapse: Patterns of care and outcomes in a series from Australia and the United Kingdom.